受激拉曼组织学有助于神经外科患者的准确诊断:一项一对一非劣效性研究
该研究在1个月内收集18例中枢神经系统病变切除术患者的组织,对同一块组织分别进行受激拉曼组织学(SRH)与冰冻切片分析,比较诊断能力并由病理学家评估组织质量与状态。SRH诊断充分率为78%,冰冻切片为94%,Fisher精确检验显示两组诊断能力无显著差异,SRH质量与组织状态均非劣于冰冻切片。
要点
- 同一组织一对一比较中,SRH诊断充分率78%,冰冻切片94%,两组诊断能力无显著差异。
- 病理学家评估SRH质量及SRH后组织状态均非劣于冰冻切片。
- 作者认为该研究为SRH非劣效性提供进一步证据,并首次证明一对一组织分析中SRH的准确性。
核心结论
- 该研究为SRH技术的非劣效性提供进一步证据,并首次证明SRH在一对一组织分析中用于神经病理标本的准确性。
研究设计与样本
- 在1个月期间收集18例接受中枢神经系统病变切除术患者的组织,对同一块组织分别进行SRH与冰冻切片分析,比较诊断能力,并由病理学家通过问卷调查评估组织质量与状态。
主要发现
- SRH诊断充分率为78%,同一标本冰冻切片诊断充分率为94%。
- Fisher精确检验显示两组诊断能力无显著差异。
- 病理学家评估SRH质量与SRH后组织状态均非劣于冰冻切片。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Stimulated Raman histology (SRH) offers efficient and accurate intraoperative neuropathological tissue analysis without procedural alteration to the diagnostic specimen. However, there are limited data demonstrating one-to-one tissue comparisons between SRH and traditional frozen sectioning. This study explores the non-inferiority of SRH as compared to frozen section on the same piece of tissue in neurosurgical patients. METHODS: Tissue was collected over a 1-month period from 18 patients who underwent resection of central nervous system lesions. SRH and frozen section analyses were compared for diagnostic capabilities as well as assessed for quality and condition of tissue via a survey completed by pathologists. RESULTS: SRH was sufficient for diagnosis in 78% of specimens as compared to 94% of specimens by frozen section of the same specimen. A Fisher's exact test determined there was no significant difference in diagnostic capability between the two groups. Additionally, both quality of SRH and condition of tissue after SRH were deemed to be non-inferior to frozen section. CONCLUSIONS: This study provides further evidence for the non-inferiority of SRH techniques. It is also the first study to demonstrate SRH accuracy using one-to-one tissue analysis in neuropathological specimens.
引用
- Einstein EH, Ablyazova F, Rosenberg A, et al. Stimulated Raman histology facilitates accurate diagnosis in neurosurgical patients: a one-to-one noninferiority study. J Neurooncol. 2022. PMID: 35764906. doi:10.1007/s11060-022-04071-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。